Searchable abstracts of presentations at key conferences in endocrinology

ea0041ep465 | Diabetes (to include epidemiology, pathophysiology) | ECE2016

Descriptive observational study of a group of diabetic patients admitted to Hospital Punta De Europa from Gibraltar area health field during the year 2015

Recio Carmen Bautista , Fernandez-Ladreda Mariana Tome , Duarte Daniel Gonzalez

Objectives: The prevalence of diabetic patients admitted in hospitals close to 20% in some series. Our goal is to determine the prevalence of diabetic patients assessed by interclinical calls from different medical and surgical specialties that have been entered during 2015 in our Hospital, in order to describe the characteristics that these diabetic patients.Material and methods: We present 116 patients evaluated by interclinical consultation request fo...

ea0037gp.14.07 | Diabetes and obesity – Clinical diabetes | ECE2015

Degree of control of type 2 diabetes in Spain according to individualised glycaemic targets

Minambres Inka , Mediavilla Jose Javier , Gonzalez-Segura Diego , Perez Antonio

Our objective was to estimate the distribution of Spanish diabetic patients attending to individualized glycaemic targets recommended by the ADA/EASD consensus with and without considering hypoglycaemia risk. We conducted a cross-sectional study in a Spanish primary care setting between 2011 and 2012. A total of 5382 type 2 diabetic subjects under antihyperglycaemic treatment for at least 3 months prior to inclusion completed a study visit in which clinical data including age,...

ea0035p182 | Cardiovascular Endocrinology & Lipid Metabolism | ECE2014

Evaluation of lipid levels in familial hypercholesterolemia in a lipid unit

Gonzalez-Molero Inmaculada , Vallejo Rosario , Omiste Antonio , Tinahones Francisco

Objective: To determine the degree of control of hypercholesterolemia in a specific lipid unit.Material and Methods: Retrospective study of patients followed in our unit over the past 16 years diagnosed with heterozygous familial hypercholesterolemia (HFH) or familial combined hyperlipidemia (FCH). Control criteria according to the following recommendations were compared: International Panel (2003), Nice (2008), NLA (2011), ESC / ESA 2011, Consensus ADA ...

ea0032p275 | Clinical case reports - Thyroid / Others | ECE2013

Submandibular ectopic thyroid gland

Dominguez-Lopez Marta , Gonzalez-Molero Inmaculada , Ruiz MSol , Soriguer Federico

Introduction: Ectopic thyroid glands are generally a rare entity appearing mostly in the cervical midline (90% of the cases) and even more rarely in other anatomical sites (10%).Clinical report: We present the case of an ectopic submandibular thyroid gland. A 31-year-old woman was referred to our department with a history of left submandibular swelling.A scintigraphy was performed, which showed an accumulation of activity in the ri...

ea0032p343 | Developmental Endocrinology | ECE2013

Evaluation of adults with phenyketonuria from pediatric to adult care

Gonzalo Montserrat , Omiste Antonio , Gonzalez Inmaculada , Dominguez Marta

Objective: Transition from pediatric to adult health care is a particularly vulnerable period for patients with inborn metabolic diseases.Our objective in this study was to evaluate the current transition of patients with phenylketonuria (PKU) in Malaga, Spain, by analysis of the metabolic control, medical care, patients satisfaction and phychosocial status.Material and methods: We evaluate all the patients transferred to our adult...

ea0032p442 | Diabetes | ECE2013

Severe diabetic ketoacidosis in type 2 diabetes mellitus

Rodriguez-Gutierrez Rene , Gonzalez-Moreno Emanuel I , Camara-Lemarroy Carlos R , Quintanilla-Flores Dania L , Gonzalez-Chavez Juan M , Galarza-Delgado Dionicio A , Tamez-Perez Hector E , Gonzalez-Gonzalez Jose G

Introduction: Severe diabetic ketoacidosis (S-DKA) is a life-threatening condition requiring immediate hospitalization and treatment. Although mostly associated with type one diabetic patients, it is also a common condition in type two diabetes mellitus (T2DM). Our objective was to determine the main clinical and metabolic alterations associated with S-DKA in T2DM patients.Methods: We retrospectively analyzed the medical records of 27 consecutive T2DM pa...

ea0032p485 | Diabetes | ECE2013

Efficacy and safety of liraglutide in morbid obese patients in first year of commercialization in Spain

Molero Inmaculada Gonzalez- , Vallejo Rosario , Dominguez Marta , Garcia-Arnes Juan

Aim: To evaluate the efficacy and safety for first patients treated in our clinic with liraglutide.Methods: Retrospective study of patients who started treatment with liraglutide in the last year in our department. We collected data on age, years of evolution, chronic complications, previous treatment, physical examination, analytical parameters and side effects.Results: Fifty-four patients. Follow-up: 4–12 months. Mean age: 5...

ea0029p1084 | Neuroendocrinology | ICEECE2012

Long term evolution of patients with transsphenoidal surgery due to pituitary adenomas

Arnes J Garcia . , Gonzalez-Molero I. , Dominguez-Lopez M.

Aim: To study the results of transsphenoidal surgery in our Neuroendocrinology Unit in last 10 years.Methods: We reviewed all patients operated in our hospital and followed in our Neuroendocrinology Unit in the last 10 years. We excluded patients with previous surgery or irradiation on this area. We obtained data about type and size of tumor, previous hormonal deficit, local symptoms,complications of surgery and the status after this (remission, persiste...

ea0029p1088 | Neuroendocrinology | ICEECE2012

Long term evolution of patients with prolactinoma in a neuroendocrinology unit

Arnes JGarcia , Gonzalez-Molero I , Dominguez-Lopez M

Aims: To know characteristics and long term evolution of patients with prolactinoma in our Neuroendocrinology Unit.Material and methods: We studied retrospectively all patients with diagnosis of prolactinoma in our Neuroendocrinology Unit in last 12 years.Results: We studied 126 patients. Predominant sex was female (69.07%), 56.7% were macroadenomas. The time from the onset of symptoms until they are seen by the specialist ranges 1...

ea0028p131 | Cytokines and growth factors | SFEBES2012

Effects of long-term intermittent administration of GH on EGF signaling in liver

Diaz Maria , Miquet Johanna , Sotelo Ana , Turyn Daniel , Gonzalez Lorena

Growth hormone (GH) is involved in body growth and metabolism. This hormone is used for the treatment of various clinical conditions and is administrated subcutaneously once daily or 3 times a week. The chronic use of GH has side effects; among them, the increase in tumor incidence. GH activates pathways related with oncogenesis not only by the activation of its specific receptor, but also by transactivation and regulation of the expression of the epidermal growth factor recep...